Free weekly newsletter
Get the free weekly contract digest
The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Zentek subsidiary awarded $1.1M contract for avian flu technology development
Nov 06, 2024•over 1 year ago
Contract Type
contract
Description
Zentek Ltd.'s subsidiary, Triera Biosciences Ltd., has been awarded a $1.1 million contract by the Government of Canada to further develop its multivalent aptamer technology for combating highly pathogenic avian influenza (HPAI) A(H5N1). The contract, part of the Innovative Solutions Canada program, aims to advance medical technologies in response to health emergencies, with a focus on developing a lead candidate for HPAI A(H5N1) within six months.
Agreement Insights
Based on industry dataContract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months